About Temprian Therapeutics
Temprian Therapeutics is a company based in Chicago (United States) founded in 2019.. Temprian Therapeutics has raised $275 thousand across 1 funding round. Temprian Therapeutics offers products and services including DNA Plasmid Treatment and Platform Technology. Temprian Therapeutics operates in a competitive market with competitors including miraDry, CERAGEM, Zeno Corporation, Therative and ThermoTek, among others.
- Headquarter Chicago, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Temprian Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$275 K (USD)
in 1 rounds
-
Latest Funding Round
$275 K (USD), Seed
Nov 19, 2019
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Temprian Therapeutics
Temprian Therapeutics offers a comprehensive portfolio of products and services, including DNA Plasmid Treatment and Platform Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Injectable therapy to reverse immune responses in vitiligo patients.
Broad technology for treating various autoimmune diseases like Hashimoto’s.
Unlock access to complete
Unlock access to complete
Funding Insights of Temprian Therapeutics
Temprian Therapeutics has successfully raised a total of $275K through 1 strategic funding round. The most recent funding activity was a Seed round of $275 thousand completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $275,000
-
First Round
First Round
(19 Nov 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Seed - Temprian Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Temprian Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Temprian Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Temprian Therapeutics Comparisons
Competitors of Temprian Therapeutics
Temprian Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as miraDry, CERAGEM, Zeno Corporation, Therative and ThermoTek, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Underarm sweat and odor glands are eliminated noninvasively.
|
|
| domain | founded_year | HQ Location |
It functions as an automatic thermal massager.
|
|
| domain | founded_year | HQ Location |
Zeno Corporation develops devices for thermal treatment of acne.
|
|
| domain | founded_year | HQ Location |
Technology news site covering innovations and industry reactions.
|
|
| domain | founded_year | HQ Location |
Thermoelectric, Thermal Management, and Medical Therapy Devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Temprian Therapeutics
When was Temprian Therapeutics founded?
Temprian Therapeutics was founded in 2019.
Where is Temprian Therapeutics located?
Temprian Therapeutics is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Who is the current CEO of Temprian Therapeutics?
Kettil Cedercreutz is the current CEO of Temprian Therapeutics.
Is Temprian Therapeutics a funded company?
Temprian Therapeutics is a funded company, having raised a total of $275K across 1 funding round to date. The company's 1st funding round was a Seed of $275K, raised on Nov 19, 2019.
What does Temprian Therapeutics do?
Temprian Therapeutics was founded in 2019 in Chicago, United States, within the biotechnology sector. Focus is placed on developing treatments for vitiligo through a modified heat shock protein, HSP70i. DNA encoding the protein is injected to halt the autoimmune response responsible for the condition. Operations center on advancing this therapeutic approach for autoimmune skin disorders.
Who are the top competitors of Temprian Therapeutics?
What products or services does Temprian Therapeutics offer?
Temprian Therapeutics offers DNA Plasmid Treatment and Platform Technology.